Loading…
← CockpitCompetitor Analysis › ACT0.DE Alzchem Group AGOpen in the cockpit ↗

Alzchem Group AGACT0.DECompetitor analysis, valuation and peers

Germany · EUR·Materials›Chemicals: Major Diversified
Mkt cap
$1.68B
US dollars, full cap
Free float
65%
of shares outstanding
$/day
$3.75M
20-day average traded
Fwd P/E
23.1×
forward earnings
ROIC−WACC
+23.9 pp
WACC 6.1%
Hurdle
-8 pp
Req g minus delivered
Next earnings
99 days
25 Feb 2027
Close · EUR€150.20
1D+1.1%
1W+4.6%
1M-6.6%
3Mn/a
6Mn/a
YTDn/a
1Yn/a
ATR %5.1%
52w lowhigh11.4% off high

What Alzchem does

Employees: 1,765

Alzchem at a glance

Size Alzchem (ACT0.DE) is a Germany Materials company (Chemicals: Major Diversified) with a market value of $1.68B, the 112th largest of 198 Germany companies the cockpit tracks. Shares closed at €150.20 on 18 Nov 2026.

Growth Revenue grew 4.8% over the last twelve months (peer median +9.1%); the operating margin is 16.0% (peer median 10.5%).

Valuation It trades at 23.1× forward earnings against a peer median of 18.4× (9th most expensive of 18).

Price implies For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -8 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 23.9 points above its cost of capital (6.1% WACC).

Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).

Alzchem financials

Reported figures in EUR; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue€581M€562M€554M€541M€542M
Revenue growth—+1%+3%0%—
Gross profit€182M€178M€163M€137M€109M
EBITDA€123M€109M€98.7M€78.1M€50.9M
Net income€65.0M€63.5M€54.1M€34.6M€30.1M
Free cash flown/a€39.2M€62.0M€52.1M-€33.3M
Capital expendituren/a€97.8M€43.1M€20.6M€29.1M
Total debt€0€44.2M€52.8M€62.5M€100M

Quarterly statements and history in the cockpit →

Alzchem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%20×40×60×4272002643BRGAARTIINDFINEORG4749IOSPPRIVISCLNGVT6885453009103010904041002585ACT0.DERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Alzchem is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%10%20%30%4272002643BRGFINEORGIOSPPRIVISCL1717NGVT3009103010904041002585ACT0.DEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Alzchem is the large dot.

Alzchem competitors and peer comparison

How Alzchem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Alzchem against its 20 peers (data as of 18 Nov 2026)
MeasureACT0.DEPeer medianRank in peer set
1-month return-6.6%-10.8%9th highest of 21
Distance from 52-week high-11.4%-37.5%4th highest of 21
Revenue growth (TTM)+4.8%+9.1%8th lowest of 21
Operating margin16.0%10.5%8th highest of 21
Forward P/E23.1×18.4×9th most expensive of 18
Growth the price implies (Req g, 7 yrs)0.5%5.8%3rd least demanding of 14
Growth delivered (Del g)+8.2%+6.9%5th highest of 14
Hurdle (Req g minus delivered)-7.7 pp+3.5 pp3rd least demanding of 14
ROIC minus cost of capital+23.9 pp-0.3 pphighest of 21
EV / EBITDA11.9×12.1×6th cheapest of 12
Net debt / EBITDA-0.5×1.2×4th least indebted of 13

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Alzchem ACT0.DEGermany$1.68Bn/a+5%16%23.1×0.5%+8.2%
Nippon Kayaku 4272.TJapan$1.71B-9%+16%10%10.5×1.7%+6.9%
Isuspecialtychemical 457190.KSSouth Korea$1.62B-32%+6%2%n/an/an/a
Valiant 002643.SZChina$1.61B-36%+3%10%26.1×17.1%+4.9%
Huntsman HUNUnited States$1.58B-36%+6%0%n/an/an/a
Borregaard BRG.OLNorway$1.58B+6%+3%17%24.0×-1.2%+7.7%
AARTI Industries AARTIIND.NSIndia$1.80B-1%+40%9%29.9×n/an/a
Fine Organic Industries FINEORG.NSIndia$1.81B+21%+13%20%33.4×28.7%+15.7%
Zhejiang Yongtai Technology 002326.SZChina$1.81B-44%+38%11%n/an/an/a
Advanced Echem Materials 4749.TWOTaiwan$1.93B-34%+20%25%33.6×n/an/a
Innospec IOSPUnited States$1.94B0%+5%8%13.8×5.0%+8.3%
Privi Speciality Chemicals PRIVISCL.NSIndia$1.44B+11%+18%20%36.4×30.6%+15.0%
Eternal Materials 1717.TWTaiwan$1.96B-29%+7%6%14.8×14.5%+1.2%
Ingevity NGVTUnited States$1.97B-12%-12%26%10.2×-1.4%-0.8%
Hubei Sinophorus Electronic Materials 688545.SSChina$2.07B-39%+75%11%62.9×n/an/a
Xinxiang Richful Lube Additive 300910.SZChina$1.36B-33%+12%16%12.2×2.1%+32.5%
Hanchem 014680.KSSouth Korea$1.35B-49%+11%17%11.6×5.8%+7.4%
Rianlon 300596.SZChina$1.35B-15%+11%11%14.2×n/an/a
China Resources Chemical Innovative Materials 301090.SZChina$1.30B-33%+4%1%18.4×20.6%+1.1%
Nippon Soda 4041.TJapan$1.29B+11%0%10%12.2×5.2%+1.8%
Jiangsu Shuangxing Color Plastic New Materials 002585.SZChina$1.27B-10%-4%-4%57.9×21.0%+0.2%

Questions

Which companies are Alzchem's closest peers?
The cockpit's peer set: Nippon Kayaku (4272.T), Isuspecialtychemical (457190.KS), Valiant (002643.SZ), Huntsman (HUN), Borregaard (BRG.OL), AARTI Industries (AARTIIND.NS), Fine Organic Industries (FINEORG.NS), Zhejiang Yongtai Technology (002326.SZ).
Is Alzchem expensive compared with its peers?
On forward p/e it trades at 23.1× against a peer median of 18.4×, 9th most expensive of 18 in its peer set. For today's price to make sense, revenue must grow about 0% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -8 pp: the price already allows for a slowdown.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.